Bemnifosbuvir/Ruzasvir Fixed Dose Combination (FDC), Sofosbuvir / Velpatasvir
AT-01B-008
Phase 3 small_molecule active
Quick answer
Bemnifosbuvir/Ruzasvir Fixed Dose Combination (FDC), Sofosbuvir / Velpatasvir for Chronic Hepatitis C Virus (HCV) Infection is a Phase 3 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Chronic Hepatitis C Virus (HCV) Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active